July 16, 2015 | By Eric Sagonowsky
Two recently-published market analyses paint a picture of a competitive but growing vaccines field through 2020, with the newest report from Tufts University stating the industry is on track to post $40 billion in annual sales in 5 years.
In its industry examination published late last week, the Tufts Center for the Study of Drug Development found that vaccines in development have more than tripled in the last decade and that vaccines sales grew 11.5% over the same period–nearly twice the 6% average annual growth of pharma sales. In a statement, lead investigator Ronald Evens said growth going forward will be driven by factors such as efforts to reduce healthcare expenses and a growing demand for cancer vaccines. A third report says sales of just cancer vaccines should grow at a compound annual growth rate of 27.24% through 2020.
Evens and colleagues found…
View original post 261 more words